Drugmaker Eli Lilly & Co is announcing a temporary shortage of two of its insulin products.
Lispro Injection are or will be temporarily out of stock at wholesalers and some pharmacies through the beginning of April," Lilly said in a recent statement.
The company said it is continuing to make the 10 mL vials, and "will ship them as soon as we can." However, in the meantime patients withmay need to consult with their doctors "to discuss switching to the same insulin in a prefilled pen or other insulin treatment options," Lilly said.
"Patients who need insulin immediately and cannot access their healthcare provider for an alternative treatment option should seek emergency care," the company added.that the “dynamic nature of insulin supply and demand, coupled with a brief delay in manufacturing, led to the temporary supply constraint.”Learn to better control your glucose levels by preventing blood sugar swings.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eli Lilly warns 2 of its insulin products may be out of stockThe shortage applies to the company's 10 mL vials of Humalog and Insulin Lispro Injection medications.
Read more »
Eli Lilly's Ad Warns Against Misuse of Diabetes and Obesity MedicationsEli Lilly releases a new ad called 'Big Night' to discourage the misuse of prescription medications developed for patients with Type 2 diabetes and obesity. The ad emphasizes that these drugs are not intended for general weight loss purposes and should only be used by those whose health is affected by obesity.
Read more »
Eli Lilly says Alzheimer’s drug approval delayed as FDA seeks input from advisersDrugmaker Eli Lilly says that approval of its experimental Alzheimer’s medication donanemab will be delayed beyond the end of March as the FDA plans to call a last-minute meeting of its advisers
Read more »
Stocks making the biggest moves midday: Nvidia, Marvell Technology, Costco, Eli Lilly and moreThese are the stocks posting the largest moves in midday trading.
Read more »
Eli Lilly's campaign seeks to resolve weight-loss drug misconceptionsEli Lilly is launching a campaign aimed at informing consumers about the seriousness of diabetes as a disease and the appropriate use of its weight-loss-related drugs.
Read more »
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients Amazon Pharmacy second online pharmacy to partner with Eli Lilly’s site, and could provide faster deliveries for certain patients.
Read more »